Discover open access scientific publications

Search, annotate, share and cite publications

Publications by James W Reagan

675 Indction of Cervical Carcinoma in the Mouse by Prolonged Genital Exposure to Formalin Inactivated Herpes Simplex Viruses Types 1 and 2 (Hsv-1 and HSV-2)

Pediatric Research

English

Related publications

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection Against HSV-1 and HSV-2 Genital Infections

English

Proportion of Herpes Simplex Virus (HSV) Type 1 and Type 2 Among Genital and Extragenital HSV Isolates

Acta Dermato-Venereologica

Dermatology

Medicine

2002

English

Cervical Antibodies in Patients With Oral Herpes Simplex Virus Type 1 (HSV-1) Infection: Local Anamnestic Responses After Genital HSV-2 Infection.

English

Comparative Evaluation of AmpliVue HSV 1+2 Assay With ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens

Journal of Clinical Microbiology

Microbiology

2015

English

Immunodominant Epitopes in Herpes Simplex Virus Type 2 Glycoprotein D Are Recognized by CD4 Lymphocytes From Both HSV-1 and HSV-2 Seropositive Subjects

Journal of Immunology

Allergy

Immunology

2008

English

The Burden of Infection With HSV-1 and HSV-2 in England and Wales: Implications for the Changing Epidemiology of Genital Herpes

Sexually Transmitted Infections

Dermatology

Infectious Diseases

2000

English

Herpes Simplex Virus 1 (HSV-1) for Cancer Treatment

English

Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis Through the Viral Ribonucleotide Reductase Large Subunit R1

English

Chemokines and Chemokine Receptors Critical to Host Resistance Following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection

The Open Immunology Journal

2008

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by James W Reagan

675 Indction of Cervical Carcinoma in the Mouse by Prolonged Genital Exposure to Formalin Inactivated Herpes Simplex Viruses Types 1 and 2 (Hsv-1 and HSV-2)

Related publications

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection Against HSV-1 and HSV-2 Genital Infections

Proportion of Herpes Simplex Virus (HSV) Type 1 and Type 2 Among Genital and Extragenital HSV Isolates

Cervical Antibodies in Patients With Oral Herpes Simplex Virus Type 1 (HSV-1) Infection: Local Anamnestic Responses After Genital HSV-2 Infection.

Comparative Evaluation of AmpliVue HSV 1+2 Assay With ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens

Immunodominant Epitopes in Herpes Simplex Virus Type 2 Glycoprotein D Are Recognized by CD4 Lymphocytes From Both HSV-1 and HSV-2 Seropositive Subjects

The Burden of Infection With HSV-1 and HSV-2 in England and Wales: Implications for the Changing Epidemiology of Genital Herpes

Herpes Simplex Virus 1 (HSV-1) for Cancer Treatment

Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis Through the Viral Ribonucleotide Reductase Large Subunit R1

Chemokines and Chemokine Receptors Critical to Host Resistance Following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection